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Abnormal sulfate metabolism in vitamin D-deficient rats
Abstract
To explore the possibility that vitamin D status regulates sulfate homeostasis, plasma sulfate levels,
renal sulfate excretion, and the expression of the renal Na-SO4 cotransporter were evaluated in vitamin
D-deficient (D-D-) rats and in D-D- rats rendered normocalcemic by either vitamin D or calcium/lactose
supplementation. D-D- rats had significantly lower plasma sulfate levels than control animals
(0.93+/-0.01 and 1.15+/-0.05 mM, respectively, P &lt; 0.05), and fractional sulfate renal excretion was
approximately threefold higher comparing D-D- and control rats. A decrease in renal cortical brush
border membrane Na-SO4 cotransport activity, associated with a parallel decrease in both renal Na-SO4
cotransport protein and mRNA content (78+/-3 and 73+/-3% decreases, respectively, compared with
control values), was also observed in D-D- rats. Vitamin D supplementation resulted in a return to
normal of plasma sulfate, fractional sulfate excretion, and both renal Na-SO4 cotransport mRNA and
protein. In contrast, renal sulfate excretion and renal Na-SO4 cotransport activity, protein abundance,
and mRNA remained decreased in vitamin D-depleted rats fed a diet supplemented with lactose and
calcium, despite that these rats were normocalcemic, and had significantly lower levels of parathyroid
hormone and 25(OH)- and 1,25(OH)2-vitamin D levels than the vitamin D-supplemented groups. These
results demonstrate that vitamin D modulates renal Na-SO4 sulfate cotransport and sulfate homeostasis.
The ability of vitamin D status to regulate Na-SO4 cotransport appears to be a direct effect, and is not
mediated by the effects of vitamin D on plasma calcium or parathyroid hormone levels. Because sulfate
is required for synthesis of essential matrix components, abnormal sulfate metabolism in vitamin
D-deficient animals may contribute to producing some of the abnormalities observed in rickets and
osteomalacia.
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Abstract
 
To explore the possibility that vitamin D status regulates
sulfate homeostasis, plasma sulfate levels, renal sulfate ex-
cretion, and the expression of the renal Na-SO
 
4
 
 cotrans-
 
porter were evaluated in vitamin D–deficient (D
 
2
 
D
 
2
 
) rats
and in D
 
2
 
D
 
2
 
 rats rendered normocalcemic by either vita-
min D or calcium/lactose supplementation. D
 
2
 
D
 
2
 
 rats had
significantly lower plasma sulfate levels than control ani-
mals (0.93
 
6
 
0.01 and 1.15
 
6
 
0.05 mM, respectively,
 
 P 
 
,
 
0.05), and fractional sulfate renal excretion was approxi-
mately threefold higher comparing D
 
2
 
D
 
2
 
 and control rats.
A decrease in renal cortical brush border membrane Na-SO
 
4
 
cotransport activity, associated with a parallel decrease in
both renal Na-SO
 
4
 
 cotransport protein and mRNA content
(78
 
6
 
3 and 73
 
6
 
3% decreases, respectively, compared with
control values), was also observed in D
 
2
 
D
 
2
 
 rats. Vitamin D
supplementation resulted in a return to normal of plasma
sulfate, fractional sulfate excretion, and both renal Na-SO
 
4
 
cotransport mRNA and protein. In contrast, renal sulfate
excretion and renal Na-SO
 
4
 
 cotransport activity, protein
abundance, and mRNA remained decreased in vitamin
D–depleted rats fed a diet supplemented with lactose and
calcium, despite that these rats were normocalcemic, and had
significantly lower levels of parathyroid hormone and 25(OH)-
and 1,25(OH)
 
2
 
-vitamin D levels than the vitamin D–supple-
mented groups. These results demonstrate that vitamin D
modulates renal Na-SO
 
4
 
 sulfate cotransport and sulfate
homeostasis. The ability of vitamin D status to regulate
Na-SO
 
4
 
 cotransport appears to be a direct effect, and is not
mediated by the effects of vitamin D on plasma calcium or
parathyroid hormone levels. Because sulfate is required for
synthesis of essential matrix components, abnormal sulfate
metabolism in vitamin D–deficient animals may contribute
to producing some of the abnormalities observed in rickets
and osteomalacia. (
 
J. Clin. Invest.
 
 1997. 100:2196–2203.) Key
words: vitamin D deficiency 
 
•
 
 Na-SO
 
4
 
 cotransporter 
 
•
 
 sul-
fate homeostasis 
 
•
 
 parathyroid hormone
 
Introduction
 
Sulfate, the fourth most abundant anion in human plasma, is
known to play an essential role in a variety of biochemical pro-
cesses. Despite its potential importance, sulfate levels are al-
most never measured in clinical practice, little is known about
the factors that regulate sulfate homeostasis in mammals, and
the possible contribution of abnormalities in the regulation of
sulfate metabolism to the pathogenesis of human diseases is
largely unexplored (1).
Sulfated proteoglycans constitute the largest group of sul-
foconjugates in mammals, and it is well established that these
proteoglycans are required for the maintenance of normal
structure and function of bone and cartilage (2, 3). Thus, it is
reasonable to postulate that diseases affecting sulfate metabo-
lism may be likely to result in abnormalities in cartilage and/or
bone. In support of this hypothesis, genetic defects involving a
sulfate transport protein (DTDST)
 
1
 
 have been shown recently
to be responsible for three different types of osteochondrodys-
plasia, diastrophic dysplasia, type IB achondrogenesis, and
type II atelosteogenesis (4–6). In these osteochondrodyspla-
sias, undersulfation of cartilage proteoglycans is associated with
abnormalities affecting the organization of collagen fibrils, the
tinctorial properties of proteoglycans, and the number and
morphology of chondrocytes. The severity of the phenotype
appears to be correlated with the predicted effect of the muta-
tions on the residual activity of the DTDST protein (6). Simi-
larly, a defect in the conversion of adenosine 5
 
9
 
-phospho-
sulfate to 3
 
9
 
-phosphoadenosine 5
 
9
 
-phosphosulfate produces
brachymorphism in mice, a disorder characterized by short
stature and associated with the production of undersulfated
proteoglycans (7).
Several considerations raise the possibility that certain of
the skeletal abnormalities seen in vitamin D deficiency could
result from abnormal sulfate metabolism. First, several patho-
logical features seen in 1,25(OH)
 
2
 
D deficiency states are not
easily explained solely by changes in calcium and phosphate
metabolism. Thus, although hypocalcemia and hypophospha-
temia easily account for the impairment in mineral deposition
typical of rickets and osteomalacia (8), the disorganization of
the chondrocyte columns seen in rachitic cartilage and the
presence of abnormalities in the maturation of chondrocytes
(8, 9) are more difficult to attribute to this mechanism. Fur-
thermore, changes in the physical properties of proteoglycan
aggregates in rachitic rat bone (10) and a reduction in sulfate
fixation in the matrix of growth plate cartilage in vitamin
D–deficient rats have also been reported (11), findings that are
consistent with the presence of abnormalities of sulfate metab-
olism in 1,25(OH)
 
2
 
D deficiency. Finally, the intestine and kid-
ney, two of the principal target organs for 1,25(OH)
 
2
 
D action,
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are also known to represent the two most important tissues
implicated in the regulation of extracellular concentrations of
inorganic sulfate (12). Nevertheless, no direct evidence for ab-
normalities in the circulating levels of sulfate in vitamin D–defi-
cient animals has been reported.
The aim of this study was to investigate the effects of vita-
min D status on sulfate homeostasis. In view of the striking
reduction in extracellular sulfate levels observed in vitamin
D–deficient animals, the mechanisms responsible were fur-
ther investigated. First, the effect of vitamin D deficiency on
renal sulfate excretion and expression of the recently de-
scribed renal Na-SO
 
4
 
 cotransporter (13) was evaluated. Sec-
ond, we sought to determine whether vitamin D deficiency per
se played a direct role in the regulation of sulfate homeostasis,
or whether the calcium deficiency and/or elevated circulating
PTH levels produced by vitamin D deficiency were causative
factors in this model.
 
Methods
 
Animals and diet.
 
The animals were divided into four groups as re-
ported (14). Briefly, a group of rats maintained on standard labo-
ratory chow containing 0.75% calcium, 0.66% phosphate, and 2,000
IU/kg vitamin D for 6 wk served as controls (control or D
 
1
 
D
 
1
 
 group).
The second group of rats was given a vitamin D–deficient diet con-
taining 0.4% calcium and 0.3% phosphate for 6 wk (vitamin D–defi-
cient or D
 
2
 
D
 
2
 
 group). The animals in groups 3 and 4 also received
the vitamin D–deficient diet for the first 5 wk. Subsequently, this diet
was supplemented during the sixth week with either 2,000 IU/kg vita-
min D (vitamin D–supplemented or D
 
2
 
D
 
1
 
 group) or 1.6% calcium
and 20% lactose (calcium/lactose-supplemented or D
 
2
 
Ca
 
1
 
 group).
Vitamin D–deficient diets supplemented with high calcium and lac-
tose have been used previously to maintain normocalcemia in vitamin
D–deficient rats (15, 16). In all cases, protein was given in the form of
casein, and the amount of inorganic sulfate in the diets was similar.
Animals were killed at 6 wk after being anesthetized by intraperito-
neal injection of phenobarbital. Plasma biochemical parameters for
the animals studied here have been reported previously (14) and are
summarized in Table I. For the study of the renal Na-SO
 
4
 
 cotrans-
porter, the kidneys were rapidly excised, immersed in liquid nitrogen,
and stored at 
 
2
 
80
 
8
 
C.
 
Measurement of plasma sulfate by capillary electrophoresis.
 
Inor-
ganic plasma sulfate and phosphate concentrations were determined
by capillary electrophoresis using a P/ACE 2100 apparatus (Beckman
Instruments, Inc., Fullerton, CA) equipped with a UV detector and
254 nm filter (17–20). Absorbance was continuously monitored using
a 20 Hz sampling rate with a 0.1-s time constant, and the area under
the peaks corresponding to the migration of sulfate, corrected for the
elution rate, was determined.
For each experiment, standard curves relating sample concentra-
tion to corrected peak area were generated using at least six different
concentrations of the standard solutions. Regression analysis demon-
strated that these standard curves were linear over the range of concen-
trations studied (0.05–1 mM) with correlation coefficients 
 
.
 
 0.998.
Each plasma sample was analyzed at two dilutions (1/4 and 1/8) in
pure bi-distilled water, and three aliquots (8 nl each) of each dilution
were assayed. For each aliquot, sulfate concentrations were deter-
mined by interpolation from the standard curve, and the six values
were averaged.
 
RNA extraction.
 
Total RNA from kidney was extracted as de-
scribed (14) using the guanidinium thiocyanate/cesium chloride method.
RNA concentrations were determined by absorbance at 260 nm, and
the integrity of the RNA species was evaluated by electrophoresis
into 1% agarose gels containing ethidium bromide. RNA prepara-
tions were stored at 
 
2
 
80
 
8
 
C until analysis.
 
Probes and ribonuclease (RNase) protection assays.
 
To produce a
plasmid from which Na-SO
 
4
 
 cotransporter riboprobe could be tran-
scribed, cDNA from rat kidney was used as template to amplify by
PCR a 266-bp fragment of the cDNA coding for the Na-SO
 
4
 
 cotrans-
porter using the oligonucleotides 5
 
9
 
-GTAGCAAGGAAGCAGAA-
TGT (upper primer) and 5
 
9
 
-ATTCACCCCCACCATCATCA (lower
primer). The 266-bp fragment (corresponding to nucleotides 109–375
in the sequence published by Markovitch et al. [13]) was cloned into
the pCR II vector (TA cloning kit; Invitrogen, San Diego, CA). The
vector was linearized with SpeI and a 373-bp radiolabeled antisense
RNA probe was generated by in vitro transcription using T7 poly-
merase and [
 
32
 
P]UTP. After hybridization with sample RNA and di-
gestion with RNases, this riboprobe produced a specific protected
fragment of 266 bp. A previously described construct containing a
fragment of the cDNA coding for GAPDH cloned into Bluescript II
SK
 
1
 
 was used to synthesize a GAPDH riboprobe of 192 bp that pro-
duced a specific protected fragment of 164 bp in the RNase protec-
tion assay (14).
To perform the RNase protection assays, 10 
 
m
 
g of total RNA ex-
tracted from the kidney of each animal was hybridized with 5
 
 3 
 
10
 
5
 
cpm Na-SO
 
4
 
 riboprobe and 5
 
 3 
 
10
 
4
 
 cpm GAPDH riboprobe over-
night at 50
 
8
 
C (14). The radioactivity present in the bands correspond-
ing to the protected fragments of the Na-SO
 
4
 
 transporter and
GAPDH riboprobes was quantified by electronic autoradiography
(InstantImager; Packard Instruments, Meriden, CT). RNase protec-
tion analysis was performed in duplicate on samples from 6–10 ani-
mals in each group. For each sample, the Na-SO
 
4
 
 transporter mRNA/
GAPDH mRNA ratio was calculated. The results obtained in the
control group (D
 
1
 
D
 
1
 
) were defined as 100%, and the results from
the three other groups of animals are expressed as a percentage of the
value obtained for control animals studied in the same experiment.
 
Preparation of brush border membranes (BBM).
 
BBM from kid-
ney cortices were prepared by a Mg
 
2
 
1
 
 precipitation method, as de-
scribed (21). After the final centrifugation, BBM were resuspended in
10 mM Tris-HCl (pH 7.0) containing 50 mM mannitol (Western blots),
or 10 mM Tris-HCl (pH 7.5) containing 300 mM mannitol (Na-SO
 
4
 
transport measurements). Protein was measured using the Coomassie
protein assay reagent (Pierce Chemical Co., Rockford, IL) based on
the Bradford method (22).
 
Table I. Biochemical Parameters in the Four Groups of Rats
 
Parameter
Experimental group
D
 
1
 
D
 
1
 
D
 
2
 
D
 
2
 
D
 
2
 
D
 
1
 
D
 
2
 
Ca
 
1
 
n 
 
5
 
 10 n 
 
5
 
 14 n 
 
5
 
 12 n 
 
5
 
 7
 
Total calcium
(mM) 2.42
 
6
 
0.05* 1.06
 
6
 
0.04
 
‡
 
2.61
 
6
 
0.05 2.51
 
6
 
0.04
Phosphate
(mM) 1.80
 
6
 
0.06
 
§
 
2.35
 
6
 
0.07 2.39
 
6
 
0.09 0.33
 
6
 
0.03
 
i
 
Creatinine
(
 
m
 
M) 51.0
 
6
 
1.5 54.5
 
6
 
1.2 51.1
 
6
 
0.8 48.8
 
6
 
2.0
25(OH)D
(ng/ml) 5.4
 
6
 
1.2
 
,
 
 1
 
¶
 
4.7
 
6
 
1.1
 
,
 
 1
 
¶
 
1,25(OH)
 
2
 
D
(pg/ml) 85
 
6
 
8 45
 
6
 
6
 
¶
 
88
 
6
 
14 51
 
6
 
8
 
¶
 
PTH
(pg/ml) 44
 
6
 
8 595
 
6
 
88
 
‡
 
104
 
6
 
37 15
 
6
 
3**
*All values are expressed as mean
 
6
 
SEM. The number of animals stud-
ied is as indicated except for creatinine (
 
n
 
 
 
5
 
 6 for each group). 
 
‡
 
P
 
 
 
,
 
 0.05
compared to the D
 
1
 
D
 
1
 
, D
 
2
 
D
 
1
 
, and D
 
2
 
Ca
 
1 
 
groups. 
 
§
 
P
 
 
 
,
 
 0.05 compared
to the D
 
2
 
D
 
2, D2D1, and D2Ca1 groups. iP , 0.05 compared to the
D2D2 and D2D1 groups. ¶P , 0.05 compared to the D1D1 and D2D1
groups. **P , 0.05 compared to the D1D1 and D2D1 groups.
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Preparation of antibodies. Polyclonal antibodies against renal
Na-SO4 cotransporter NaSi-1 (13) were raised in rabbits by immuni-
zation with a fusion protein containing a 53–amino acid polypeptide de-
rived from the Na-SO4 cotransporter sequence. This antibody prepa-
ration specifically detected a 68-kD protein on Western blots of
proteins isolated from renal BBM and specifically stained proximal
tubular BBM in renal tissue evaluated using immunohistochemical
techniques (23). A second nonspecific band of apparent molecular
mass of 70 kD was also detected with the antibody. As previously re-
ported (23), the reactivity of the antibody with this band is not pre-
vented in the presence of the antigenic fusion protein, and the expres-
sion of this band is not regulated.
BBM protein electrophoresis and Western blots. Experiments were
performed as described (24). Briefly, BBM proteins were denatured
in 95 mM Tris-HCl (pH 6.8) containing 2% SDS, 10% glycerol, 0.5 mM
EDTA, and 100 mM dithiothreitol (final concentrations). 35 mg BBM
protein per lane was electrophoresed on 10% polyacrylamide gels ac-
cording to Laemmli (25), and the samples were electrotransferred
onto nitrocellulose membranes. After blocking the membrane with
Tris-buffered saline (pH 7.4) containing 5% skimmed dried milk and
1% Triton X-100, membranes were incubated overnight with a 1:5,000
dilution of the polyclonal antibody specific for the Na-SO4 cotrans-
porter NaSi-1. Antibody binding was detected by chemiluminescence
using the ECL Western blotting protocol (Amersham Life Science,
Buckinghamshire, UK) as described by the manufacturer, using a
donkey anti–rabbit whole antibody linked to horseradish peroxidase.
Signals recorded on x-ray film were quantified by densitometric scan-
ning and peaks integrated using the Image Quant software package
(Molecular Dynamics Inc., Sunnyvale, CA). Western blots were per-
formed on BBM prepared from kidneys obtained from three rats in
each group. Results are expressed relative to values obtained for the
control rats (D1D1 group) studied in each series of experiments.
Equal loading was ensured by protein staining of gels run in parallel.
BBM Na-SO4 transport measurements. Measurement of Na-SO4
transport was performed on freshly isolated BBM vesicles using a
procedure based on radioisotope uptake followed by rapid Millipore
filtration, as described (26, 27). Suspensions of BBM were equili-
brated at room temperature for 1 h in preloading buffer (10 mM Tris-
HCl, pH 7.5, containing 300 mM mannitol). 30 mg of BBM suspended
in 10 ml of preloading buffer was then mixed at room temperature
with 40 ml of extravesicular uptake buffer containing 50 mCi/ml
H2[35S]SO4 (43 Ci/mg; ICN Biomedicals, Costa Mesa, CA) to produce
solutions containing (final concentrations) 5 mM Tris-HCl (pH 7.5),
100 mM mannitol, and either 100 mM Na-gluconate (Na-dependent
uptake) or 100 mM potassium gluconate (Na-independent uptake) in
the presence of 0.05–5 mM K2[35S]SO4. Uptake was terminated after
90 s by the addition of 2 ml of ice-cold stop solution (10 mM Tris-
HCl, pH 7.5, containing 300 mM mannitol, 2 mM CaCl2, and 1 mM
HgCl2) (28) and filtration of the suspension across a 0.45-mm pore
membrane (HAWP; Millipore Corp., Milford, MA). Filters were then
washed four additional times with 2 ml stop solution, and radioactiv-
ity was counted. [35S]SO4 specific activity was determined experimen-
tally for each series of measurements. Na-dependent SO4 uptake was
calculated by subtracting the uptake measured under Na1-free condi-
tions from that observed in the presence of Na1 at each K2SO4 con-
centration. Results are expressed as nanomoles of SO4 per 90 s per
milligram of protein.
Urinary sulfate excretion. Urinary sulfate excretion was measured
on nine vitamin-deficient rats (seven D2D2, two D2Ca1), and six vi-
tamin D–supplemented rats (four D1D1, two D2D1). Anesthesia,
surgical preparation of the animals, and infusion of [3H]inulin were
performed as previously described (29, 30). H2[35S]SO4 (43 Ci/mg; ICN
Biomedicals) was suspended in 0.15 M NaCl and administered by in-
travenous infusion at a rate of 50 ml/min per 100 g body wt until a to-
tal dose of 100 mCi/200 g body wt had been administered. Inulin and
sulfate clearances were measured as previously reported (29, 30).
Presentation of data and statistical analysis. Results are presented
as mean6SEM unless otherwise stated. Samples from the different
groups of rats were evaluated simultaneously in all experiments. Sta-
tistical comparisons were performed by one-way ANOVA; compari-
sons between individual groups were made using the Fisher LSD test
(31). Fractional sulfate excretion was expressed as a function of uri-
nary output, and results were analyzed by comparing the regression
lines obtained for the vitamin D–supplemented and the vitamin-defi-
cient rats (31). P values , 0.05 were considered significant.
Results
Effects of vitamin D deficiency and vitamin D supplementation 
on sulfate homeostasis
Inorganic plasma sulfate concentrations. The mean plasma sul-
fate concentration of vitamin D–deficient rats (D2D2 group)
was significantly lower than that of control rats (D1D1 group)
(0.9360.01 and 1.1560.05 mM, respectively, P , 0.05). When
vitamin D–deficient animals received a diet containing vita-
min D supplementation for 1 wk before evaluation, however,
plasma sulfate levels were similar to those of control animals
(1.2260.03 mM, P . 0.2 comparing the D2D1 group and
D1D1 group).
Na-SO4 cotransporter mRNA expression. Because renal re-
absorption of sulfate is important in maintaining plasma sul-
fate levels within a normal range, abnormalities in the expres-
sion of the renal Na-SO4 transporter represent a possible cause
of hyposulfatemia seen in vitamin D–deficient rats. To explore
this possibility, mRNA coding for the Na-SO4 cotransporter
was measured in kidney from vitamin D–deficient and control
animals using RNase protection analysis (Fig. 1). In all experi-
ments, the amount of Na-SO4 cotransporter mRNA in kidney
from the vitamin D–deficient rats (D2D2 group) was found to
be reduced compared with that obtained in kidneys from con-
trol animals (D1D1 group). Overall, the ratio of counts per
minute in the bands corresponding to the protected fragments
of Na-SO4 cotransporter mRNA and GAPDH mRNA was re-
duced by 7363% compared with vitamin D–deficient and con-
trol animals (Fig. 1 B, P , 0.05). As was observed for plasma
sulfate levels, Na-SO4 cotransporter mRNA levels were nor-
mal in vitamin D–deficient animals that received vitamin D
supplementation for 1 wk before time of killing (9568% of
control values, Fig. 1). Similar changes were not observed
for Na-PO4 cotransporter type II mRNA (32) as previously
reported in similar experimental conditions (33) (data not
shown).
Na-SO4 cotransporter protein abundance. To determine
whether the reduction in mRNA coding for the Na-SO4
cotransporter seen in vitamin D–deficient animals was associ-
ated with reduced expression of the cotransporter protein,
BBM were isolated from kidney cortex, and Na-SO4 cotrans-
porter protein was measured by Western blotting. Vitamin D
deficiency was associated with a 7863% decrease in the abun-
dance of the Na-SO4 cotransport protein (Fig. 2, P , 0.05 com-
paring vitamin D–deficient animals and controls). Strikingly,
vitamin D supplementation of previously vitamin D–deficient
animals for 1 wk before time of killing led to an increase in Na-
SO4 cotransporter protein expression to levels similar to those
observed in the control animals (Fig. 2, 78616% of control
values, P . 0.2 comparing animals in the D2D1 and D1D1
groups). In contrast to Na-SO4 cotransporter protein expres-
sion, no decrease in the Na-PO4 cotransporter protein type II
was seen when the same blots were probed with an antibody
raised against a NH2-terminal peptide of the Na-PO4 cotrans-
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porter type II (data not shown). The presence of a decreased
Na-SO4 cotransporter in absence of a decreased Na-PO4
cotransporter underlines the fact that the changes in Na-SO4
cotransporter are not one of multiple impairments of sodium-
coupled cotransporters in renal proximal tubules.
BBM Na-SO4 cotransport activity. In agreement with the
decrease in Na-SO4 cotransporter protein expression, vitamin D
deficiency caused a significant decrease in BBM Na-SO4 co-
transport activity (Fig. 3). Studies evaluating the kinetics of
Na-dependent SO4 cotransport as a function of extravesicular
SO4 concentration indicated that vitamin D deprivation caused
a decrease in the Vmax of Na-SO4 cotransport, without chang-
ing the affinity of the transporter for SO4 (Fig. 3, inset).
Effect of calcium supplementation on sulfate homeostasis in 
vitamin D–deficient rats
It was of interest to determine whether the hyposulfatemia
and changes in renal Na-SO4 cotransport as observed in vita-
min D–deficient rats were a direct consequence of vitamin D
deficiency, or whether secondary changes resulting from vita-
min D deficiency, such as hypocalcemia and/or hyperparathy-
roidism, were more directly involved in producing the changes
in sulfate metabolism. To evaluate this question, rats receiving
a vitamin D–deficient diet that was supplemented with high
calcium and lactose during the final week before time of killing
were also studied. As expected, calcium/lactose supplementa-
tion (D2Ca1 group) produced an increase in plasma calcium to
levels similar to those of control animals (Table I). Plasma
PTH concentrations decreased substantially in these normo-
calcemic rats, whereas plasma 25(OH)D and 1,25(OH)2 con-
centrations remained significantly lower than those of control
rats (Table I). As was observed for calcium concentrations,
plasma sulfate concentrations in the rats receiving lactose/cal-
cium supplementation also increased to levels that were not
significantly different from those of control animals (1.0960.01
Figure 1. RNase protection analysis of Na-SO4 cotransporter mRNA 
expression in kidney obtained from control (D1D1), vitamin D–defi-
cient (D2D2), and vitamin D–supplemented (D2D1) rats. (A) 10 mg 
of total RNA from kidney of control (1), vitamin D–deficient (2), 
and vitamin D–supplemented (2/1) rats was hybridized with radiola-
beled riboprobes recognizing Na-SO4 cotransporter and GAPDH 
mRNAs, incubated in the presence of RNases, and the protected 
fragments were separated by acrylamide gel electrophoresis. (A) Au-
toradiographs of the protected fragments from three different experi-
ments (1, 2, and 3) are presented. (B) Quantification of Na-SO4 
mRNA. Radioactivity (counts per minute) present in the bands cor-
responding to the protected fragments of Na-SO4 cotransporter and 
GAPDH riboprobes was determined by electronic autoradiography, 
and the ratio of the counts per minute for the Na-SO4 cotransport 
mRNA band over the counts in the GAPDH mRNA band was calcu-
lated. Results for each animal were then expressed as a percentage of 
the average results obtained for control (D1D1) rats evaluated in the 
same experiment. Shown are the mean6SEM of results obtained for 
8 animals in the D1D1 group, and 10 animals in the D2D2 and D2D1 
groups. The result for one rat is the mean of two determinations. 
*P , 0.05 compared with the D1D1 and D2D1 groups.
Figure 2. Immunoblotting of Na-SO4 cotransporter protein in BBM. 
35 mg of BBM protein freshly prepared from the renal cortices was 
separated by SDS-PAGE and transferred to nitrocellulose mem-
branes as described in Methods. Blots were incubated sequentially 
with a polyclonal rabbit anti–Na-SO4 cotransporter (NaSi-1) antibody 
and a donkey anti–rabbit whole antibody linked to horseradish per-
oxidase, and antibody binding was detected by chemiluminescence 
using the ECL Western blotting protocol (Amersham Life Science). 
(A) Example of results obtained using BBM proteins prepared from 
kidneys of control (D1D1), vitamin D–deficient (D2D2), and vitamin 
D–supplemented (D2D1) rats in one experiment. (B) Quantification 
of Na-SO4 cotransporter protein expression. Bands corresponding to 
the Na-SO4 cotransporter were quantitated by densitometry, and re-
sults are expressed as a percentage of the result obtained for the con-
trol (D1D1) rat evaluated in the same experiment. Shown are the 
mean6SEM for three experiments. *P , 0.05 compared with the 
D1D1 and D2D1 groups. The upper band is a nonspecific band de-
tected by the antibody, as described in Methods and reference 23.
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and 1.1560.05 mM in the D2Ca1 and D1D1 groups, respec-
tively).
In contrast to the striking effect observed in response to
vitamin D supplementation, however, treatment of vitamin
D–deficient rats with calcium/lactose supplementation did not
change renal Na-SO4 cotransport. Thus, despite the normaliza-
tion of plasma calcium and the marked decrease in plasma
PTH levels observed in calcium/lactose-supplemented animals,
renal Na-SO4 cotransport steady state mRNA levels, protein
abundance, and activity were reduced to a similar extent in the
D2D2 and D2Ca1 groups compared with the control (D1D1)
group (Table II).
Effect of vitamin D status on urinary sulfate excretion
To directly evaluate whether the changes in renal Na-SO4
cotransport activity observed in vitamin D–deficient animals
resulted in changes in renal handling of sulfate, urinary sulfate
excretion in vivo was evaluated in vitamin D–deficient and
control rats. Glomerular filtration rates were not significantly
modified by vitamin D status (0.4860.04 vs. 0.5860.09 ml/min
per 100 g of body wt, mean6SEM, respectively, in vitamin
D–depleted [n 5 9] and vitamin D–repleted [n 5 6] rats, P .
0.2). As shown in Fig. 4, the fractional excretion of sulfate in
these animals varied as a function of urinary output. Impor-
tantly, for any given level of urinary output, fractional sulfate
excretion was approximately threefold higher comparing vita-
Figure 3. Effect of vitamin D deficiency on the kinet-
ics of Na-SO4 cotransport in BBM. Na-dependent 
SO422 uptake by BBM from control (D1D1, squares) 
and vitamin D–deficient rats (D2D2, triangles) was 
measured as a function of the concentration of extra-
vesicular sulfate, and is presented as nanomoles of 
SO422 per milligram of protein per 90 s. Kinetic pa-
rameters were calculated by nonlinear curve fitting, 
assuming Michaelis-Menton kinetics, and the data (in-
set) are the mean6SEM obtained from the study of 
BBM preparations from kidneys obtained from five 
different rats in each group. For each point, uptake 
measurements were performed in triplicate. The 
graph presents representative results obtained for one 
rat from each group in a single experiment. Na-depen-
dent SO4 uptake was calculated by subtracting the up-
take measured under Na1-free conditions from that 
observed in the presence of Na1 at each K2SO4 con-
centration. *P , 0.05 compared with D1D1 group.
Table II. Effect of Calcium Supplementation on Na-SO4 
Cotransport mRNA Expression, Protein Abundance, and 
Activity in Vitamin D–deficient Rats
Parameter
Experimental group
D1D1 D2D2 D2Ca1
mRNA expression*‡
100619 2763§ 3062§(% control)
Immunoreactive protein*i
10063 2263§ 4062§(% control)
Na-SO4 cotransport activity¶
Vmax (nmol SO4/mg protein/90 s) 7.3461.47 5.6361.36§ 4.1160.81§
Km (mM SO4) 0.6260.04 0.7160.09 0.7660.12
All results are the mean6SEM. *Results are expressed as the percent-
age of the average value obtained for the control (D1D1) animals eval-
uated in each experiment. ‡Experiments were performed in duplicate
on samples from 8 (D1D1 group), 10 (D2D2 group), and 6 (D2Ca1
group) animals. §P , 0.05 compared to D1D1 group. in 5 3 for all
groups. ¶Experiments were performed in triplicate on kidneys from five
different rats in each group.
Figure 4. Effect of vitamin D status on sulfate excretion. Fractional 
excretion of sulfate (FE SO4) and urinary output ( ) were measured 
as described in Methods in nine vitamin D–deficient rats (open trian-
gles, D2D2; closed triangles, D2Ca1) and six vitamin D–supple-
mented rats (open squares, D1D1; closed squares, D2D1). Results 
were analyzed by comparing the regression lines obtained for the vi-
tamin D–supplemented and the vitamin-deficient rats. *P , 0.05 
compared with the vitamin D–supplemented group.
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min D–deficient with vitamin D–supplemented rats (Fig. 4). It
is noteworthy that the important increase in sulfate excretion
contrasted with a modest decrease (z 30%) of sulfate filtered
load, due to the slight decreases of sulfatemia and glomerular
filtration rate. Compatible with the lack of effect of calcium/
lactose supplementation on renal Na-SO4 cotransport mRNA
expression, protein abundance and activity, fractional sulfate
excretion was not different comparing vitamin D–deficient an-
imals that did or did not receive calcium/lactose supplementa-
tion (Fig. 4).
Discussion
Inorganic sulfate is essential for a variety of metabolic pro-
cesses, and sulfate requirements in man and other mammalian
species appear to change as a function of growth and age (34–
36). Thus, mechanisms permitting the regulation of plasma sul-
fate levels are likely to be important for normal physiology,
and abnormalities in these processes may contribute to the
pathogenesis of various diseases. This study demonstrates for
the first time that the expression and activity of the recently
cloned renal sodium-sulfate cotransporter, renal sulfate han-
dling, and serum sulfate concentrations are concomitantly reg-
ulated by vitamin D status.
Plasma sulfate levels, renal Na-SO4 cotransport expression,
and renal sulfate handling were evaluated in vitamin D–defi-
cient rats and in vitamin D–deficient animals rendered normo-
calcemic by either vitamin D or calcium/lactose supplementa-
tion. Vitamin D–deficient rats developed hyposulfatemia and
decreased renal Na-SO4 cotransport activity measured in BBM
vesicles. This decrease in renal Na-SO4 cotransport activity re-
sulted from a decrease in the Vmax of the transport system, and
was accompanied by parallel decreases in both Na-SO4 co-
transport protein and mRNA content. Furthermore, it was as-
sociated with an increase in the fractional excretion of sulfate,
strongly suggesting that the changes in Na-SO4 cotransporter
activity directly influence renal sulfate excretion, and thereby
contribute to the observed changes in plasma sulfate. It is
noteworthy that the decrease in plasma sulfate was more mod-
erate than might have been anticipated from the large increase
in urinary sulfate excretion observed in vitamin D–depleted
animals. These findings suggest that additional changes are oc-
curring that partially compensate for the increased renal sul-
fate excretion in vitamin D–deficient animals. Modulation of
intestinal absorption of sulfate could participate. Intestinal sul-
fate absorption depends, at least in part, on sodium-dependent
transport, and the intestinal Na-SO4 cotransporter is known to
be the same as that expressed in the kidney (12, 13). Whether
vitamin D status also regulates the intestinal Na-SO4 cotrans-
porter remains to be determined. It is also possible that vita-
min D deficiency results in increased sulfate release from bone.
In this regard, no information is available concerning the regu-
lation by vitamin D of the sulfate transport protein DTDST
expressed in bone (4). Clearly, definition of the relative contri-
bution of renal sulfate excretion, intestinal absorption, and re-
lease from bone in modulating serum sulfate in vitamin D defi-
ciency will require further study.
Vitamin D supplementation resulted in a return of both re-
nal cortical Na-SO4 cotransport mRNA and protein to normal
levels, changes that were associated with a normalization of
fractional sulfate excretion and correction of the hyposul-
fatemia. Prior studies have indicated that sex, menstrual cycle,
pregnancy, and thyroid hormone can influence plasma SO4
levels (1), but the mechanisms involved have not been defined.
Regulation of renal BBM Na-SO4 cotransport activity by glu-
cocorticoids (37) and thyroid hormone has also been reported
(38), although the latter finding was not confirmed in all stud-
ies (39). In neither case, however, were changes in Na-SO4
cotransport activity demonstrated to produce changes in renal
sulfate handling or serum sulfate levels. In addition, changes in
Na-SO4 cotransport activity have not been shown previously to
result from regulation of the expression of Na-SO4 cotransport
protein or mRNA, as demonstrated in this study.
Renal Na-SO4 cotransport activity, protein abundance, and
mRNA levels remained decreased, and fractional excretion of
sulfate remained increased in vitamin D–deficient rats that re-
ceived calcium/lactose supplementation. These rats had nor-
mal plasma calcium concentrations, but lower 1,25(OH)2D lev-
els than the rats that had received vitamin D supplementation
(D1D1 and D2D1 groups). Because hypocalcemia and ele-
vated PTH levels were corrected in animals receiving either vi-
tamin D supplements or lactose and calcium, whereas renal
Na-SO4 cotransport was corrected only by vitamin D supple-
mentation, these results indicate that it is the vitamin D status,
most likely the active metabolite 1,25(OH)2D, not plasma cal-
cium or PTH levels, that regulates the expression and activity
of the renal Na-SO4 cotransporter in this model. Similarly, sev-
eral findings indicate that plasma phosphate is unlikely to be
implicated in the regulation of renal Na-SO4 cotransport ex-
pression and activity in our model. First, the two vitamin
D–deficient groups (D2D2 and D2Ca1 groups) had signifi-
cantly different plasma phosphate levels but similar Na-SO4
cotransport expression and activity. Conversely, vitamin
D–deficient animals that did (D2D1 group) or did not receive
vitamin D supplementation (D2D2 group) had similar phos-
phate levels, but significantly different levels of expression of
renal Na-SO4 cotransport mRNA and protein.
Interestingly, sulfatemia was normal in vitamin D–deficient
animals receiving lactose and calcium, despite that renal Na-
SO4 cotransport activity and expression remained decreased
and fractional sulfate excretion remained increased in these
animals. This implies that the renal transport of sulfate is still
compromised in this group of animals as a consequence of the
persistent vitamin D deficiency. These findings also indicate
the restoration of plasma sulfate must have resulted from
changes independent of renal sulfate transport, such as in-
creased intestinal absorption of sulfate. As discussed above,
changes in the activity of the intestinal Na-SO4 cotransporter
could potentially contribute to the regulation of serum sulfate.
Alternatively, increased intestinal absorption of sulfate could
occur in this group of rats by a mechanism independent of
Na-SO4 cotransport activity. In this regard, a lactose-induced
enhancement of the passive (or diffusional) component of
calcium transport has been suggested to explain the ability of
lactose to increase intestinal calcium absorption (15, 16). An
analogous mechanism might be responsible for increasing in-
testinal sulfate uptake, thereby increasing serum sulfate con-
centrations.
A deficit in sulfate occurring in vitamin D deficiency may
have important clinical implications. Proteoglycans are ex-
tremely important for the maintenance of the normal structure
and function of bone and cartilage. Sulfation of all naturally
occurring sulfated compounds, including proteoglycans, de-
pends on the availability of inorganic sulfate, which is the pre-
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cursor of 39-phosphoadenosine 59-phosphosulfate (PAPS), the
activated form of sulfate (40). Recently, several inherited forms
of osteochondrodysplasia have been shown to result from ab-
normalities in sulfate transport or metabolism (4–6). A limi-
tation in the availability of inorganic SO4 produced by an
acquired defect may also result in abnormal sulfation of pro-
teoglycans. Altered proteoglycan synthesis by aortic endothe-
lial cells (41) and epiphyseal cartilage (42) maintained in vitro
in medium containing low sulfate concentrations has been ob-
served. Thus, by regulating renal sulfate transport and sul-
fatemia, vitamin D status would appear to be a major factor
influencing the amount of inorganic sulfate available for sulfa-
tion of proteoglycans.
In conclusion, these results demonstrate that vitamin D sta-
tus modulates renal Na-SO4 sulfate cotransport and sulfate ho-
meostasis, and thereby influences the amount of inorganic sul-
fate available for sulfation of proteoglycans. Therefore, vitamin
D deficiency may result in a defect in the synthesis of these im-
portant matrix components, a mechanism that may contribute
to producing some of the abnormalities observed in rickets
and osteomalacia. As it has been demonstrated by in vitro
studies that PTH can directly stimulate the sulfation of pro-
teoglycans (43), the regulation of sulfate metabolism, like that
of calcium and phosphate, appears to be subject to coordinate
regulation by both PTH and vitamin D.
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